US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
- Posted on August 28, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
Aug 28 (Reuters) - Eli Lilly said on Friday the U.S. FDA has approved its diabetes drug Mounjaro to reduce the chances of heart attack or stroke in adults with type 2 diabetes who are at high risk of cardiovascular events. The approval expands the use of Mounjaro, which targets the GLP-1 protein, beyond blood sugar control. In the U.S., Lilly sells the obesity version of the drug under the brand
